Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Growth 2022-2028
Small nucleic acid drugs are short in length and have a base of less than 30 nt. They mainly act on mRNA in cells through the principle of complementary base pairing to regulate protein expression, thereby achieving therapeutic effects. It can be further divided into single-stranded antisense oligonucleotide ASO, and double-stranded nucleotide siRNA.
The global market for Antisense oligonucleotides (ASO) Drug and siRNA Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Antisense oligonucleotides (ASO) Drug and siRNA Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Antisense oligonucleotides (ASO) Drug and siRNA Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Antisense oligonucleotides (ASO) Drug and siRNA Drug players cover Alnylam, Ionis, Biogen, Novartis and Sarepta Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Antisense oligonucleotides (ASO) Drug and siRNA Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Antisense oligonucleotides (ASO) Drug and siRNA Drug market, with both quantitative and qualitative data, to help readers understand how the Antisense oligonucleotides (ASO) Drug and siRNA Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Antisense oligonucleotides (ASO) Drug and siRNA Drug market and forecasts the market size by Type (Antisense Oligonucleotides (ASO) Drug and siRNA Drug,), by Application (Single Gene Rare Disease, Protein Deposition Disease, Chronic Liver Disease and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Antisense Oligonucleotides (ASO) Drug
siRNA Drug
Segmentation by application
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Alnylam
Ionis
Biogen
Novartis
Sarepta Therapeutics
Therapeutics
Akcea
WAVElife
ProQR
Exicure
Secarna
AstraZeneca
The WhiteOak Group, Inc.
Dicerna
Silence
Arrowhead
Miragen Therapeutics
Genzyme
Quark Pharmaceuticals
Sylentis
Avidity Biosciences
Chapter Introduction
Chapter 1: Scope of Antisense oligonucleotides (ASO) Drug and siRNA Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Antisense oligonucleotides (ASO) Drug and siRNA Drug market size (sales and revenue) and CAGR, Antisense oligonucleotides (ASO) Drug and siRNA Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Antisense oligonucleotides (ASO) Drug and siRNA Drug sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Antisense oligonucleotides (ASO) Drug and siRNA Drug sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Antisense oligonucleotides (ASO) Drug and siRNA Drug market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Alnylam, Ionis, Biogen, Novartis, Sarepta Therapeutics, Therapeutics, Akcea, WAVElife and ProQR, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Antisense oligonucleotides (ASO) Drug and siRNA Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Antisense oligonucleotides (ASO) Drug and siRNA Drug by Country/Region, 2017, 2022 & 2028
2.2 Antisense oligonucleotides (ASO) Drug and siRNA Drug Segment by Type
2.2.1 Antisense Oligonucleotides (ASO) Drug
2.2.2 siRNA Drug
2.3 Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type
2.3.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sale Price by Type (2017-2022)
2.4 Antisense oligonucleotides (ASO) Drug and siRNA Drug Segment by Application
2.4.1 Single Gene Rare Disease
2.4.2 Protein Deposition Disease
2.4.3 Chronic Liver Disease
2.4.4 Other
2.5 Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application
2.5.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sale Price by Application (2017-2022)
3 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug by Company
3.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Breakdown Data by Company
3.1.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Annual Sales by Company (2020-2022)
3.1.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Company (2020-2022)
3.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Company (2020-2022)
3.2.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Company (2020-2022)
3.3 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sale Price by Company
3.4 Key Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Location Distribution
3.4.2 Players Antisense oligonucleotides (ASO) Drug and siRNA Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antisense oligonucleotides (ASO) Drug and siRNA Drug by Geographic Region
4.1 World Historic Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Annual Revenue by Geographic Region
4.2 World Historic Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Annual Revenue by Country/Region
4.3 Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Growth
4.4 APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Growth
4.5 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Growth
4.6 Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Growth
5 Americas
5.1 Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country
5.1.1 Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2017-2022)
5.1.2 Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Country (2017-2022)
5.2 Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type
5.3 Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region
6.1.1 APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region (2017-2022)
6.1.2 APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Region (2017-2022)
6.2 APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type
6.3 APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug by Country
7.1.1 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2017-2022)
7.1.2 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Country (2017-2022)
7.2 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type
7.3 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug by Country
8.1.1 Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type
8.3 Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antisense oligonucleotides (ASO) Drug and siRNA Drug
10.3 Manufacturing Process Analysis of Antisense oligonucleotides (ASO) Drug and siRNA Drug
10.4 Industry Chain Structure of Antisense oligonucleotides (ASO) Drug and siRNA Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antisense oligonucleotides (ASO) Drug and siRNA Drug Distributors
11.3 Antisense oligonucleotides (ASO) Drug and siRNA Drug Customer
12 World Forecast Review for Antisense oligonucleotides (ASO) Drug and siRNA Drug by Geographic Region
12.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Region
12.1.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Forecast by Region (2023-2028)
12.1.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Forecast by Type
12.7 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Forecast by Application
13 Key Players Analysis
13.1 Alnylam
13.1.1 Alnylam Company Information
13.1.2 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.1.3 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Alnylam Main Business Overview
13.1.5 Alnylam Latest Developments
13.2 Ionis
13.2.1 Ionis Company Information
13.2.2 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.2.3 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Ionis Main Business Overview
13.2.5 Ionis Latest Developments
13.3 Biogen
13.3.1 Biogen Company Information
13.3.2 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.3.3 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biogen Main Business Overview
13.3.5 Biogen Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.4.3 Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Sarepta Therapeutics
13.5.1 Sarepta Therapeutics Company Information
13.5.2 Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.5.3 Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sarepta Therapeutics Main Business Overview
13.5.5 Sarepta Therapeutics Latest Developments
13.6 Therapeutics
13.6.1 Therapeutics Company Information
13.6.2 Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.6.3 Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Therapeutics Main Business Overview
13.6.5 Therapeutics Latest Developments
13.7 Akcea
13.7.1 Akcea Company Information
13.7.2 Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.7.3 Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Akcea Main Business Overview
13.7.5 Akcea Latest Developments
13.8 WAVElife
13.8.1 WAVElife Company Information
13.8.2 WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.8.3 WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 WAVElife Main Business Overview
13.8.5 WAVElife Latest Developments
13.9 ProQR
13.9.1 ProQR Company Information
13.9.2 ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.9.3 ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 ProQR Main Business Overview
13.9.5 ProQR Latest Developments
13.10 Exicure
13.10.1 Exicure Company Information
13.10.2 Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.10.3 Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Exicure Main Business Overview
13.10.5 Exicure Latest Developments
13.11 Secarna
13.11.1 Secarna Company Information
13.11.2 Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.11.3 Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Secarna Main Business Overview
13.11.5 Secarna Latest Developments
13.12 AstraZeneca
13.12.1 AstraZeneca Company Information
13.12.2 AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.12.3 AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 AstraZeneca Main Business Overview
13.12.5 AstraZeneca Latest Developments
13.13 The WhiteOak Group, Inc.
13.13.1 The WhiteOak Group, Inc. Company Information
13.13.2 The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.13.3 The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 The WhiteOak Group, Inc. Main Business Overview
13.13.5 The WhiteOak Group, Inc. Latest Developments
13.14 Dicerna
13.14.1 Dicerna Company Information
13.14.2 Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.14.3 Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Dicerna Main Business Overview
13.14.5 Dicerna Latest Developments
13.15 Silence
13.15.1 Silence Company Information
13.15.2 Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.15.3 Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Silence Main Business Overview
13.15.5 Silence Latest Developments
13.16 Arrowhead
13.16.1 Arrowhead Company Information
13.16.2 Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.16.3 Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Arrowhead Main Business Overview
13.16.5 Arrowhead Latest Developments
13.17 Miragen Therapeutics
13.17.1 Miragen Therapeutics Company Information
13.17.2 Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.17.3 Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Miragen Therapeutics Main Business Overview
13.17.5 Miragen Therapeutics Latest Developments
13.18 Genzyme
13.18.1 Genzyme Company Information
13.18.2 Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.18.3 Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Genzyme Main Business Overview
13.18.5 Genzyme Latest Developments
13.19 Quark Pharmaceuticals
13.19.1 Quark Pharmaceuticals Company Information
13.19.2 Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.19.3 Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Quark Pharmaceuticals Main Business Overview
13.19.5 Quark Pharmaceuticals Latest Developments
13.20 Sylentis
13.20.1 Sylentis Company Information
13.20.2 Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.20.3 Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Sylentis Main Business Overview
13.20.5 Sylentis Latest Developments
13.21 Avidity Biosciences
13.21.1 Avidity Biosciences Company Information
13.21.2 Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
13.21.3 Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Avidity Biosciences Main Business Overview
13.21.5 Avidity Biosciences Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Antisense oligonucleotides (ASO) Drug and siRNA Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Antisense oligonucleotides (ASO) Drug and siRNA Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotides (ASO) Drug
Table 4. Major Players of siRNA Drug
Table 5. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type (2017-2022) & (K Units)
Table 6. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Type (2017-2022)
Table 7. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Type (2017-2022) & ($ million)
Table 8. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Type (2017-2022)
Table 9. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application (2017-2022) & (K Units)
Table 11. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application (2017-2022)
Table 12. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Application (2017-2022)
Table 13. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Application (2017-2022)
Table 14. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Company (2020-2022) & (K Units)
Table 16. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Company (2020-2022)
Table 17. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Company (2020-2022)
Table 19. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Producing Area Distribution and Sales Area
Table 21. Players Antisense oligonucleotides (ASO) Drug and siRNA Drug Products Offered
Table 22. Antisense oligonucleotides (ASO) Drug and siRNA Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share Geographic Region (2017-2022)
Table 27. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country/Region (2017-2022)
Table 31. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2017-2022) & (K Units)
Table 34. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country (2017-2022)
Table 35. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Country (2017-2022)
Table 37. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type (2017-2022) & (K Units)
Table 38. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Type (2017-2022)
Table 39. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application (2017-2022) & (K Units)
Table 40. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application (2017-2022)
Table 41. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region (2017-2022) & (K Units)
Table 42. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region (2017-2022)
Table 43. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Region (2017-2022)
Table 45. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type (2017-2022) & (K Units)
Table 46. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Type (2017-2022)
Table 47. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application (2017-2022) & (K Units)
Table 48. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application (2017-2022)
Table 49. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2017-2022) & (K Units)
Table 50. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country (2017-2022)
Table 51. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Country (2017-2022)
Table 53. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type (2017-2022) & (K Units)
Table 54. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Type (2017-2022)
Table 55. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application (2017-2022) & (K Units)
Table 56. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Antisense oligonucleotides (ASO) Drug and siRNA Drug
Table 66. Key Market Challenges & Risks of Antisense oligonucleotides (ASO) Drug and siRNA Drug
Table 67. Key Industry Trends of Antisense oligonucleotides (ASO) Drug and siRNA Drug
Table 68. Antisense oligonucleotides (ASO) Drug and siRNA Drug Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Antisense oligonucleotides (ASO) Drug and siRNA Drug Distributors List
Table 71. Antisense oligonucleotides (ASO) Drug and siRNA Drug Customer List
Table 72. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Forecast by Region
Table 74. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share Forecast by Application (2023-2028)
Table 92. Alnylam Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 94. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Alnylam Main Business
Table 96. Alnylam Latest Developments
Table 97. Ionis Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 99. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Ionis Main Business
Table 101. Ionis Latest Developments
Table 102. Biogen Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 104. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Biogen Main Business
Table 106. Biogen Latest Developments
Table 107. Novartis Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 109. Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Novartis Main Business
Table 111. Novartis Latest Developments
Table 112. Sarepta Therapeutics Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 114. Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Sarepta Therapeutics Main Business
Table 116. Sarepta Therapeutics Latest Developments
Table 117. Therapeutics Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 119. Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Therapeutics Main Business
Table 121. Therapeutics Latest Developments
Table 122. Akcea Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 124. Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Akcea Main Business
Table 126. Akcea Latest Developments
Table 127. WAVElife Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 129. WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. WAVElife Main Business
Table 131. WAVElife Latest Developments
Table 132. ProQR Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 134. ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. ProQR Main Business
Table 136. ProQR Latest Developments
Table 137. Exicure Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 139. Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Exicure Main Business
Table 141. Exicure Latest Developments
Table 142. Secarna Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 144. Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Secarna Main Business
Table 146. Secarna Latest Developments
Table 147. AstraZeneca Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 149. AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. AstraZeneca Main Business
Table 151. AstraZeneca Latest Developments
Table 152. The WhiteOak Group, Inc. Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 154. The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. The WhiteOak Group, Inc. Main Business
Table 156. The WhiteOak Group, Inc. Latest Developments
Table 157. Dicerna Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 158. Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 159. Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Dicerna Main Business
Table 161. Dicerna Latest Developments
Table 162. Silence Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 163. Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 164. Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Silence Main Business
Table 166. Silence Latest Developments
Table 167. Arrowhead Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 168. Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 169. Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Arrowhead Main Business
Table 171. Arrowhead Latest Developments
Table 172. Miragen Therapeutics Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 173. Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 174. Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Miragen Therapeutics Main Business
Table 176. Miragen Therapeutics Latest Developments
Table 177. Genzyme Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 178. Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 179. Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Genzyme Main Business
Table 181. Genzyme Latest Developments
Table 182. Quark Pharmaceuticals Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 183. Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 184. Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. Quark Pharmaceuticals Main Business
Table 186. Quark Pharmaceuticals Latest Developments
Table 187. Sylentis Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 188. Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 189. Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 190. Sylentis Main Business
Table 191. Sylentis Latest Developments
Table 192. Avidity Biosciences Basic Information, Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 193. Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Offered
Table 194. Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 195. Avidity Biosciences Main Business
Table 196. Avidity Biosciences Latest Developments
List of Figures
Figure 1. Picture of Antisense oligonucleotides (ASO) Drug and siRNA Drug
Figure 2. Antisense oligonucleotides (ASO) Drug and siRNA Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Antisense Oligonucleotides (ASO) Drug
Figure 10. Product Picture of siRNA Drug
Figure 11. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Type in 2021
Figure 12. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Type (2017-2022)
Figure 13. Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumed in Single Gene Rare Disease
Figure 14. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market: Single Gene Rare Disease (2017-2022) & (K Units)
Figure 15. Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumed in Protein Deposition Disease
Figure 16. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market: Protein Deposition Disease (2017-2022) & (K Units)
Figure 17. Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumed in Chronic Liver Disease
Figure 18. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market: Chronic Liver Disease (2017-2022) & (K Units)
Figure 19. Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumed in Other
Figure 20. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market: Other (2017-2022) & (K Units)
Figure 21. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application (2017-2022)
Figure 22. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Application in 2021
Figure 23. Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Company in 2021
Figure 25. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Geographic Region in 2021
Figure 27. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region (2017-2022)
Figure 28. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Country/Region in 2021
Figure 29. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales 2017-2022 (K Units)
Figure 30. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue 2017-2022 ($ Millions)
Figure 31. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales 2017-2022 (K Units)
Figure 32. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue 2017-2022 ($ Millions)
Figure 33. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales 2017-2022 (K Units)
Figure 34. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue 2017-2022 ($ Millions)
Figure 37. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country in 2021
Figure 38. Americas Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Country in 2021
Figure 39. United States Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region in 2021
Figure 44. APAC Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Regions in 2021
Figure 45. China Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country in 2021
Figure 52. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Country in 2021
Figure 53. Germany Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Country in 2021
Figure 60. Egypt Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Antisense oligonucleotides (ASO) Drug and siRNA Drug in 2021
Figure 66. Manufacturing Process Analysis of Antisense oligonucleotides (ASO) Drug and siRNA Drug
Figure 67. Industry Chain Structure of Antisense oligonucleotides (ASO) Drug and siRNA Drug
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets